http://orcid.org/0000-0002-4943-9116
References
- Lindberg U, Svensson L, Hellmark T, et al. Increased platelet activation occurs in cystic fibrosis patients and correlates to clinical status. Thromb Res. 2018;162(3):32–37.
- Lindberg U, Carlsson M, Hellmark T, et al. BPI-ANCA provides additional clinical information to anti-Pseudomonas serology: results from a cohort of 117 Swedish cystic fibrosis patients. J Immunol Res. 2015;2015(262):1–8.
- Esquivel-Valerio JA1, Flores-Suárez LF, Rodríguez-Amado J, et al. Antineutrophil cytoplasm autoantibodies in patients with tuberculosis are directed against bactericidal/permeability increasing protein and are detected after treatment initiation. Clin Exp Rheumatol. 2010;28(1 Suppl 57):35–39.
- Vestbo J, Hurd SS, Aa G. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary (updated 2014). J Chron Obstruct Pulmon Dis. 2014;1(1):103–104.
- Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654.
- Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–968.
- Crapo RO, Casaburi R, Coates AL, et al. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–117.
- Schultz H. From infection to autoimmunity: a new model for induction of ANCA against the bactericidal/permeability increasing protein (BPI). Autoimmun Rev. 2007;6(4):223–227.
- Konstantinov KN, Ulff-Moller CJ, Tzamaloukas AH. Infections and antineutrophil cytoplasmic antibodies: triggering mechanisms. Autoimmun Rev. 2015;14(3):201–203.
- Agrawal MB, Awad NT. Correlation between six minute walk test and spirometry in chronic pulmonary disease. J Clin Diagn Res. 2015;9(8):1–4.
- Karloh M, Fleig MA, Maurici R, et al. The COPD assessment test: what do we know so far? A systematic review and meta-analysis about clinical outcomes prediction and classification of patients into GOLD stages. Chest. 2016;149(2):413–425.
- Pascal OI, Trofor AC, Lotrean LM, et al. Depression, anxiety and panic disorders in chronic obstructive pulmonary disease patients: correlations with tobacco use, disease severity and quality of life. Tob Induc Dis. 2017;15(1):23–27.
- Gallego M, Pomares X, Espasa M, et al. Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors. BMC Pulm Med. 2014;14(1):103–114.
- Lindberg U, Carlsson M, Löfdahl CG, et al. BPI-ANCA and long-term prognosis among 46 adult CF patients: a prospective 10-year follow-up study. Clin Dev Immunol. 2012;2012:1–8.